NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients

Research unit

INNOSUISSE

Project number

136.004 IP-LS

Project title

NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	NanoZymeX develops lipid nanoparticle?based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients.